By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Amarantus BioSciences, Inc.  

675 Almanor Avenue

Sunnyvale  California  94085  U.S.A.
Phone: 408-737-2734 Fax: 408-852-4427



Company News
Amarantus BioSciences, Inc. Appoints Elise Brownell, Ph.D., As Senior Vice President Of Operations And Project Management 12/11/2014 7:40:14 AM
Amarantus BioSciences, Inc. Appoints Renowned Drug Development Expert And Co-Founder Of Amgen (AMGN), Joseph Rubinfeld, Ph.D., To Its Board Of Directors 12/8/2014 8:37:52 AM
Amarantus BioSciences, Inc. Announces Positive Preclinical Data On The Effects Of MANF On Vision In A Model Of Retinitis Pigmentosa 11/25/2014 9:50:54 AM
Amarantus BioSciences, Inc. Reports Third Quarter 2014 Financial Results And Enters Into Strategic Preferred Financing 11/10/2014 7:44:32 AM
Amarantus BioSciences, Inc. Applies To FDA For MANF Orphan Drug Designation In Retinitis Pigmentosa 10/16/2014 7:53:16 AM
Amarantus BioSciences, Inc. Announces Positive LP-002 Data For Alzheimer's Blood Diagnostic Lympro Test® 10/9/2014 7:38:57 AM
Amarantus BioSciences, Inc. Investigator Presents Positive MANF Animal Data In Central Retinal Vein Occlusion And Glaucoma At The Targeting Ocular Disorders Conference 10/7/2014 7:48:05 AM
Amarantus BioSciences, Inc. Requests Pre-IND Feedback From FDA For Eltoprazine Phase 2ib Parkinson's Disease Levodopa-Induced Dyskinesia Clinical Trial 9/29/2014 1:11:40 PM
Amarantus BioSciences, Inc. Shareholders Approve All Matters Voted Upon At Annual Shareholders Meeting 9/26/2014 7:04:32 AM
Amarantus BioSciences, Inc. Provides Program Update On Phase 2b Eltoprazine For Parkinson's Disease And Adult ADHD 9/17/2014 10:06:41 AM